SFL’s Senior Regulatory Affairs Manager Anja Bührer will join the Swissmedic info days on the revision of the Therapeutic Products Act (HMG), taking place on 25 October and 9 November 2018.

During the two info days, Swissmedic will provide detailed information on the upcoming regulatory and operational changes that will come into force at the beginning of 2019, following the second ordinary revision of the HMG and the publication of the updated guidelines and forms by Swissmedic on 30 September 2018.

SFL’s Regulatory Affairs Department is closely monitoring the revision and provides comprehensive support to help pharmaceutical companies act proactively upon these changes and comply with the new legal framework. Please get in touch with us if you wish to arrange a meeting with Anja during the event.